A home-based colorectal cancer early screening product that detects multi-gene mutations combined with DNA methylation in fecal exfoliated cells from the intestinal tract. It features 6 target genes and over 30 mutation sites, enabling non-invasive and painless screening that can identify colorectal...
Manufactured by
China
Suzhou Linaxin Biotechnology Co., Ltd. manufactures solid-state nanopore gene detection equipment, including solid-state nanopore detectors, nanopore chips, and supporting microfluidic devices. The company also produces medical diagnostic products for gastrointestinal and cancer early screening applications. No certification information was provided in the available content.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 13 relevant products
Clinomics Europe Kft.
Hungary · 1 relevant product
Futurlab - REVISTA NEWSLAB
Brazil · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 9 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 3 relevant products
S&T BioMed CO., LTD.
Taiwan · 2 relevant products
U-GEN BIOTECHNOLOGY INC.
China · 2 relevant products
Preventis GmbH
Germany · 3 relevant products
Genetic Tools, LLC
United States · 1 relevant product
Biomerica, Inc.
United States · 2 relevant products
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A diagnostic test kit for the combined detection of multiple gene methylation markers in blood samples for colorectal cancer screening and detection using methylation analysis technology.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A diagnostic test kit for the combined detection of multiple gene methylations in blood samples for colorectal cancer screening and diagnosis. This in vitro diagnostic reagent kit utilizes methylation detection technology to identify cancer-related biomarkers.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A diagnostic test kit for detecting multiple gene methylation markers in blood samples for intestinal cancer screening and diagnosis. The product is marketed under the brand name Chang Ai Ke® and represents an in vitro diagnostic solution for cancer detection.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized DNA methylation-based test for early detection and diagnosis of colorectal cancer. The test provides risk stratification and early screening capabilities for colorectal malignancies.
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
Futurlab - REVISTA NEWSLAB · Brazil
A non-invasive DNA-based colorectal cancer screening test that enables simple sample collection. ColoSeek represents a new generation of colorectal cancer detection technology.
Singlera GENOMICS (SHANGHAI) Ltd. · China
PCR-based fluorescence detection kit for identifying multi-gene methylation patterns in colorectal cancer screening and diagnosis. Enables risk stratification, early detection, treatment guidance, and post-operative monitoring through molecular analysis of epigenetic biomarkers.
BioChain (Beijing) Science & Technology. Inc. · China
The world's first approved gene methylation early detection product for esophageal cancer, representing a breakthrough in early cancer diagnosis. This product has received NMPA certification and is part of BioChain's comprehensive digestive system cancer screening portfolio.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
BioChain (Beijing) Science & Technology. Inc. · China
A blood-based gene methylation early detection product for colorectal cancer that was the first in China to receive NMPA approval and is marketed under the brand name Siboding®. The product has received authorizations from the FDA, NMPA, and EU CE, representing the world's earliest simultaneous approval from all three major regulatory bodies.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products